Aspects of the clinical pharmacology of verapamil, a calcium‐entry antagonist

R. G. McAllister; Scott R. Hamann; Michael T. Piascik

doi:10.1002/bdd.2510040302

Aspects of the clinical pharmacology of verapamil, a calcium‐entry antagonist

R. G. McAllister
, Scott R. Hamann
, Michael T. Piascik

Pharmacology and Nutritional Sciences

Producción científica: Review article › revisión exhaustiva

11 Citas (Scopus)

Idioma original	English
Páginas (desde-hasta)	203-211
Número de páginas	9
Publicación	Biopharmaceutics and Drug Disposition
Volumen	4
N.º	3
DOI	https://doi.org/10.1002/bdd.2510040302
Estado	Published - 1983

ASJC Scopus subject areas

Pharmacology
Pharmaceutical Science
Pharmacology (medical)

Acceder al documento

10.1002/bdd.2510040302

Otros archivos y enlaces

Citar esto

@article{707649adf9d1470c97db752b16162f94,

title = "Aspects of the clinical pharmacology of verapamil, a calcium‐entry antagonist",

keywords = "Assay methods, Clinical pharmacology, Plasma levels, Verapamil",

author = "McAllister, \{R. G.\} and Hamann, \{Scott R.\} and Piascik, \{Michael T.\}",

year = "1983",

doi = "10.1002/bdd.2510040302",

language = "English",

volume = "4",

pages = "203--211",

number = "3",

}

TY - JOUR

T1 - Aspects of the clinical pharmacology of verapamil, a calcium‐entry antagonist

AU - McAllister, R. G.

AU - Hamann, Scott R.

AU - Piascik, Michael T.

PY - 1983

Y1 - 1983

KW - Assay methods

KW - Clinical pharmacology

KW - Plasma levels

KW - Verapamil

UR - https://www.scopus.com/pages/publications/0020634860

UR - https://www.scopus.com/pages/publications/0020634860#tab=citedBy

U2 - 10.1002/bdd.2510040302

DO - 10.1002/bdd.2510040302

M3 - Review article

C2 - 6354294

AN - SCOPUS:0020634860

SN - 0142-2782

VL - 4

SP - 203

EP - 211

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

IS - 3

ER -

Aspects of the clinical pharmacology of verapamil, a calcium‐entry antagonist

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto